Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3137-3144

  Sobti, Ranbir C ^a   Thakur, Hitender ^a   Gupta, Lipsy ^a   Janmeja, Ashok K ^b   Seth, Amlesh ^c   Singh, Sharwan K ^d  

^a PANJAB UNIVERSITY   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

AAT; BPH; COPD; HPC ELAC 2 polymorphisms; Prostate cancer

Indexed keywords

DNA;

AAT GENE; ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIETARY INTAKE; DNA EXTRACTION; DRINKING BEHAVIOR; GENDER; GENE; GENETIC POLYMORPHISM; GENOTYPE; HPC ELAC 2 GENE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PROSTATE CANCER; PROSTATE HYPERTROPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SMOKING;

ALPHA 1-ANTITRYPSIN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 80052483810     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-9984-6     Document Type: Article

References (38)

1. Pienta KJ, Esper PS (1993) Is dietary fat a risk factor for prostate cancer? J Natl Cancer Inst 85:1538-1540 (Pubitemid 23304674)
2. Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJU Int 90:174-184 (Pubitemid 34779588)
3. Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB (2000) Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 67:1014-1019
4. Suarez BK, Gerhard DS, Lin J, Haberer B, Nguyen L, Kesterson NK, Catalona WJ (2001) Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res 61:4982-4984 (Pubitemid 32681523)
5. Rokman A, Ikonen T, Mononen N, Autio V, Matikainen MP, Koivisto PA, Tammela TLJ, Kallioniemi OP, Schleutker J (2001) ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res 61:6038-6041 (Pubitemid 32762535)
6. Vesprini D, Nam RK, Trachtenberg J, Jewett MA, Tavtigian SV, Emami M, Ho M, Toi A, Narod SA (2001) HPC2 variants and screen-detected prostate cancer. Am J Hum Genet 68:912-917 (Pubitemid 32289737)
7. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN (2001) Role of HPC2/ ELAC2 in hereditary prostate cancer. Cancer Res 61:6494-6499 (Pubitemid 32783256)
8. Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang B, Bailey-Wilson JER, Walsh PC, Trent JM, Meyers DA, Isaacs WB (2001) Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet 68:901-911 (Pubitemid 32289736)
9. Lomas DA, Silverman EK (2001) The genetics of chronic obstructive pulmonary disease. Respir Res 2:20-26 (Pubitemid 34187903)
10. Tobin MJ, Cook PJ, Hutchison DC (1983) Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z: a survey by the British Thoracic Association. Br J Dis Chest 77:14-27 (Pubitemid 13183041)
11. Brantly M, Nukiwa T, Crystal RG (1988) Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84:13-31
12. Carrell RW, Lomas DA, Sidhar S, Foreman R (1996) Alpha 1-antitrypsin deficiency: a conformational disease. Chest 110: 243S-247S (Pubitemid 26425182)
13. Mahadeva R, Lomas DA (1998) Genetics and respiratory disease. 2 Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 53:501-505
14. Eriksson S (1996) A 30-year perspective on alpha 1-antitrypsin deficiency. Chest 110:237S-242S (Pubitemid 26425181)
15. Mastrangeli A, Crystal RG (1996) Alpha 1-antitrypsin: an introduction. In: Crystal RG (ed) Alpha 1-antitrypsin deficiency, biology, pathogenesis, clinical manifestations, therapy. Marcel Dekker, Inc, New York, pp 3-18
16. Kueppers F, Briscoe WA, Bearn AG (1964) Hereditary deficiency of serum alpha-l-antitrypsin. Science 146:1678-1679
17. Jeppsson JO (1976) Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ. FEBS Lett 65:195-197
18. Owen MC, Carrell RW, Brennan SO (1976) The abnormality of the S variant of human alpha-1-antitrypsin. Biochim Biophys Acta 453:257-261
19. Crystal RG (1989) The alpha 1-antitrypsin gene and its deficiency states. Trends Genet 5:411-417 (Pubitemid 20011533)
20. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG (1988) Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138:327-336
21. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 1-18
22. Dry PJ (1991) Rapid detection of alpha-1-antitrypsin deficiency by analysis of a PCR-induced TaqI restriction site. Hum Genet 87:742-744
23. Tavtigian SV, Simard J, Teng DHF, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, Morrison JM, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland Ann-Marie, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon- Albright LA (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27:172-180 (Pubitemid 32157444)
24. Stanford JL, Sabacan LP, Noonan EA, Iwasaki L, Shu J, Feng Z, Ostrander EA (2003) Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer Epidemiol Biomarkers Prev 12:876-881 (Pubitemid 37151523)
25. Takahashi H, Lu W, Watanabe M, Katoh T, Furusato M, Tsukino H, Nakao H, Sudo A, Suzuki H, Akakura K, Ikemoto I, Asano K, Ito T, Wakui S, Muto T, Hano H (2003) Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. Int J Cancer 107:224-228 (Pubitemid 37152901)
26. Noonan-Wheeler FC, Wu W, Roehl KA, Klim A, Haugen J, Suarez BK, Kibel AS (2006) Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. Prostate 66:49-56 (Pubitemid 43005948)
27. Meitz JC, Edwards SM, Easton DF, Murkin A, Ardern-Jones A, Jackson RA, Williams S, Dearnaley DP, Stratton MR, Houlston RS, Eeles RA (2002) HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease. Br J Cancer 87:905-908 (Pubitemid 35252968)
28. Sandford AJ, Weir TD, Spinelli JJ, Pare PD (1999) Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 20:287-291 (Pubitemid 129504889)
29. Cox DW, Woo SL, Mansfield T (1985) DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature 316:79-81 (Pubitemid 15013719)
30. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG (2002) Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 136:270-279 (Pubitemid 34150756)
31. Seersholm N, Wilcke JT, Kok-Jensen A, Dirksen A (2000) Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 161:81-84 (Pubitemid 30055906)
32. Lieberman J, Winter B, Sastre A (1986) Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 89:370-373 (Pubitemid 16126301)
33. Janus ED (1988) Alpha 1-antitrypsin Pi types in COPD patients. Chest 94:446-447
34. Tarjan E, Magyar P, Váczi Z, Lantos A, Vaszár L (1994) Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Eur Respir J 7:2199-2204
35. Larson RK, Barman ML, Kueppers F, Fudenberg HH (1970) Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med 72:627-632
36. Kueppers F, Miller RD, Gordon H et al (1977) Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 63:336-342 (Pubitemid 8190924)
37. Rybicki BA, Beaty TH, Cohen BH (1990) Major genetic mechanisms in pulmonary function. J Clin Epidemiol 43:667-675 (Pubitemid 20232521)
38. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, Wain J, Speizer FE (1998) Genetic epidemiology of severe, earlyonset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157:1770-1778